4.8 Article

Au nanoparticles/PAMAM dendrimer functionalized wired ethyleneamine-viologen as highly efficient interface for ultra-sensitive α-fetoprotein electrochemical immunosensor

期刊

BIOSENSORS & BIOELECTRONICS
卷 59, 期 -, 页码 389-396

出版社

ELSEVIER ADVANCED TECHNOLOGY
DOI: 10.1016/j.bios.2014.03.049

关键词

Electrochemical immunosensor; Au nanoparticles; PAMAM dendrimer; Cancer biomarker; alpha-Fetoprotein (AFP)

资金

  1. Iranian Nanotechnology Initiative and the Research Office of the University of Kurdistan

向作者/读者索取更多资源

In this work, a novel electrochemical immunoassay system is developed for ultrasensitive detection of cancer biomarker, alpha-fetoprotein (AFP). This immunosensor is constructed by covalent immobilization of polyamidoamine (PAMAM) dendrimer-encapsulated gold nanoparticles (Au-PAMAM) sensing interface on a Au electrode surface, followed by sequential covalent immobilization of ethyleneamineviologen (Via) electrochemical redox marker and AFP monoclonal antibody (mAb) on the surface of Au-PAMAM. The Au-PAMAM nanocomposite not only led to increase the electrode surface area and accelerate the electron transfer kinetics, but also it could provide a highly stable matrix for the convenient conjugation of biomolecules. Upon immunorecognition of the immobilized AFP to its antibody, the Vio peak current decreased due to the hindered electron transfer reaction on the electrode surface. Through the differential pulse voltammetry (DPV) experiments, it is found that the proposed method could detect AFP antigen at a wide linear range (0.001-45 ng mL(-1)) and a detection limit down to 130 fg mL(-1). The immunosensor exhibited high specificity for AFP detection, extremely short incubation time (5 min), good stability and acceptable reproducibility. Moreover, the fabricated immunosensor could accurately detect AFP concentration in human serum samples demonstrated by excellent correlations with standard ELISA immunoassay. In addition, electrochemical impedance spectroscopy technique was used as an efficient alternative detection system for AFP measurement with detection limit 0.5 ng mL(-1) and concentration range up to 40 ng mL(-1). The present protocol is shown to be quite promising for clinical screening of cancer biomarkers and point-of-care diagnostics applications. (C) 2014 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据